€49.90 – €139.90 Inc. VAT
- Description
- Additional information
Description
Setipiprant is an investigational drug developed for the treatment of asthma and scalp hair loss. It was originally developed by Actelion and acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).
For research use only.
Additional information
Amount: | 5 gr, 10 gr, 15 gr |
---|
Reviews
There are no reviews yet.